{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:18:21Z","timestamp":1790223501895,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jisakos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of ISAKOS"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jisako.2023.07.010","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T07:01:30Z","timestamp":1691478090000},"page":"215-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Review of Dohan Eherenfest et\u00a0al. (2009) on \u201cClassification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)\u201d"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1698-9517","authenticated-orcid":false,"given":"Theodorakys","family":"Mar\u00edn Ferm\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4895-1046","authenticated-orcid":false,"given":"Jacob G.","family":"Calcei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7691-4728","authenticated-orcid":false,"given":"Franco","family":"Della Vedova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Martinez Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Arias Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus W.","family":"Laupheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0003-6305","authenticated-orcid":false,"given":"Pieter","family":"D'Hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jisako.2023.07.010_bib1","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1177\/03635465211037343","article-title":"Current trends in orthobiologics: an 11-year review of the orthopaedic literature","volume":"50","author":"Obana","year":"2022","journal-title":"Am J Sports Med"},{"issue":"1","key":"10.1016\/j.jisako.2023.07.010_bib2","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1038\/s41598-021-83025-2","article-title":"Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: correct dose critical for long term clinical efficacy","volume":"11","author":"Bansal","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jisako.2023.07.010_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0363546516643716","article-title":"The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials","volume":"45","author":"Fitzpatrick","year":"2017","journal-title":"Am J Sports Med"},{"issue":"11","key":"10.1016\/j.jisako.2023.07.010_bib4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1302\/2633-1462.111.BJO-2020-0159","article-title":"The use of biologics in professional and Olympic sport: a scoping review protocol","volume":"1","author":"Makaram","year":"2020","journal-title":"Bone Jt Open"},{"issue":"2","key":"10.1016\/j.jisako.2023.07.010_bib5","article-title":"Injectable orthobiologics in professional football (Soccer) players: a systematic review","volume":"2","author":"Mar\u00edn Ferm\u00edn","year":"2022","journal-title":"J\u00a0Cartilage Joint Preservation"},{"issue":"10","key":"10.1016\/j.jisako.2023.07.010_bib6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/bioengineering9100580","article-title":"The top 100 most cited articles on platelet-rich plasma use in regenerative medicine-A bibliometric analysis-from the ESSKA orthobiologic initiative","volume":"9","author":"Coulange Zavarro","year":"2022","journal-title":"Bioengineering (Basel)"},{"issue":"6","key":"10.1016\/j.jisako.2023.07.010_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/23259671211015667","article-title":"Biologic association annual summit: 2020 report","volume":"9","author":"Frank","year":"2021","journal-title":"Orthop J Sports Med"},{"issue":"2","key":"10.1016\/j.jisako.2023.07.010_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/09537104.2020.1832653","article-title":"Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine","volume":"32","author":"Magalon","year":"2021","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.jisako.2023.07.010_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol"},{"issue":"3","key":"10.1016\/j.jisako.2023.07.010_bib10","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.tripleo.2005.07.008","article-title":"Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution","volume":"101","author":"Dohan","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"10.1016\/j.jisako.2023.07.010_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tripleo.2006.08.034","article-title":"Why the platelet-rich gel has anti-microbial activity?","volume":"103","author":"Cieslik-Bielecka","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"10.1016\/j.jisako.2023.07.010_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/jor.20519","article-title":"Anti-microbial activity of platelet-leukocyte gel against Staphylococcus aureus","volume":"26","author":"Moojen","year":"2008","journal-title":"J\u00a0Orthop Res"},{"issue":"4","key":"10.1016\/j.jisako.2023.07.010_bib13","first-page":"661","article-title":"Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties","volume":"78","author":"El-Sharkawy","year":"2007","journal-title":"J\u00a0Periodontol"},{"issue":"5","key":"10.1016\/j.jisako.2023.07.010_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/00365510260296492","article-title":"Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets","volume":"62","author":"Werther","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"10.1016\/j.jisako.2023.07.010_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jor.20278","article-title":"Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons","volume":"25","author":"Schnabel","year":"2007","journal-title":"J\u00a0Orthop Res"},{"issue":"7","key":"10.1016\/j.jisako.2023.07.010_bib16","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/138920112800624382","article-title":"Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF)","volume":"13","author":"Dohan Ehrenfest","year":"2012","journal-title":"Curr Pharmaceut Biotechnol"},{"issue":"4","key":"10.1016\/j.jisako.2023.07.010_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tripleo.2010.05.059","article-title":"Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in human cell cultures: growth factor release and contradictory results","volume":"110","author":"Dohan Ehrenfest","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"6","key":"10.1016\/j.jisako.2023.07.010_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1600-0501.2006.01179.x","article-title":"Flow cytometric and morphological characterization of platelet-rich plasma gel","volume":"17","author":"Fern\u00e1ndez-Barbero","year":"2006","journal-title":"Clin Oral Implants Res"},{"issue":"2","key":"10.1016\/j.jisako.2023.07.010_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1423-0410.2009.01188.x","article-title":"Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: fibrinet, RegenPRP-Kit, Plateltex and one manual procedure","volume":"97","author":"Mazzucco","year":"2009","journal-title":"Vox Sang"},{"issue":"Suppl 1","key":"10.1016\/j.jisako.2023.07.010_bib20","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jcot.2019.05.008","article-title":"Leukocyte-rich PRP versus leukocyte-poor PRP - the role of monocyte\/macrophage function in the healing cascade","volume":"10","author":"Lana","year":"2019","journal-title":"J\u00a0Clin Orthop Trauma"},{"issue":"2","key":"10.1016\/j.jisako.2023.07.010_bib21","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1016\/j.asmr.2021.10.004","article-title":"Double-spin leukocyte-rich platelet-rich plasma is predominantly lymphocyte rich with notable concentrations of other white blood cell subtypes","volume":"4","author":"Marathe","year":"2021","journal-title":"Arthrosc Sports Med Rehabil"},{"issue":"3","key":"10.1016\/j.jisako.2023.07.010_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/23259671221084706","article-title":"Leukocyte-rich platelet-rich plasma has better stimulating effects on tenocyte proliferation compared with leukocyte-poor platelet-rich plasma","volume":"10","author":"Lin","year":"2022","journal-title":"Orthop J Sports Med"},{"key":"10.1016\/j.jisako.2023.07.010_bib23","article-title":"Comparative evaluation of leukocyte- and platelet-rich plasma and pure platelet-rich plasma for cartilage regeneration","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jisako.2023.07.010_bib24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0363546515580787","article-title":"Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis","volume":"44","author":"Riboh","year":"2016","journal-title":"Am J Sports Med"},{"issue":"3","key":"10.1016\/j.jisako.2023.07.010_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/03635465211064303","article-title":"Leukocyte-rich versus leukocyte-poor platelet-rich plasma for the treatment of knee osteoarthritis: a double-blind randomized trial","volume":"50","author":"Di Martino","year":"2022","journal-title":"Am J Sports Med"},{"issue":"6","key":"10.1016\/j.jisako.2023.07.010_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2106\/JBJS.20.02258","article-title":"The effect of leukocyte concentration on platelet-rich plasma injections for knee osteoarthritis: a network meta-analysis","volume":"104","author":"Abbas","year":"2022","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"6","key":"10.1016\/j.jisako.2023.07.010_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/23259671211011948","article-title":"Adverse reactions and clinical outcomes for leukocyte-poor versus leukocyte-rich platelet-rich plasma in knee osteoarthritis: a systematic review and meta-analysis","volume":"9","author":"Kim","year":"2021","journal-title":"Orthop J Sports Med"},{"issue":"1","key":"10.1016\/j.jisako.2023.07.010_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/19476035221074003","article-title":"Assessment of clinical, tissue, and cell-level metrics identify four biologically distinct knee osteoarthritis patient phenotypes","volume":"13","author":"Mantripragada","year":"2022","journal-title":"Cartilage"},{"issue":"13","key":"10.1016\/j.jisako.2023.07.010_bib29","first-page":"3891","article-title":"Effect of combined intraosseous and intraarticular infiltrations of autologous platelet-rich plasma on subchondral bone marrow mesenchymal stromal cells from patients with hip osteoarthritis","volume":"11","author":"Ganguly","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.jisako.2023.07.010_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90174-x","article-title":"In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis","volume":"11","author":"Zahir","year":"2021","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.jisako.2023.07.010_bib31","first-page":"4514","article-title":"Predictors of effectiveness of platelet-rich plasma therapy for knee osteoarthritis: a retrospective cohort study","volume":"10","author":"Saita","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"8","key":"10.1016\/j.jisako.2023.07.010_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1302\/0301-620X.101B8.BJJ-2019-0037.R1","article-title":"Classification systems for platelet-rich plasma","volume":"101-B","author":"Rossi","year":"2019","journal-title":"Bone Joint Lett J"},{"issue":"7","key":"10.1016\/j.jisako.2023.07.010_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.arthro.2012.04.148","article-title":"Platelet-rich plasma: the PAW classification system","volume":"28","author":"DeLong","year":"2012","journal-title":"Arthroscopy"},{"issue":"7","key":"10.1016\/j.jisako.2023.07.010_bib34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2174\/138920112800624283","article-title":"Sports medicine applications of platelet rich plasma","volume":"13","author":"Mishra","year":"2012","journal-title":"Curr Pharmaceut Biotechnol"},{"issue":"4 Suppl","key":"10.1016\/j.jisako.2023.07.010_bib35","first-page":"S53","article-title":"A\u00a0call for a standard classification system for future biologic research: the rationale for new PRP nomenclature","volume":"7","author":"Mautner","year":"2015","journal-title":"PM R"},{"issue":"1","key":"10.1016\/j.jisako.2023.07.010_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2015-000060","article-title":"DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices","volume":"2","author":"Magalon","year":"2016","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"5","key":"10.1016\/j.jisako.2023.07.010_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/rme-2017-0042","article-title":"Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL","volume":"12","author":"Lana","year":"2017","journal-title":"Regen Med"},{"issue":"9","key":"10.1016\/j.jisako.2023.07.010_bib38","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/jth.14223","article-title":"The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH","volume":"16","author":"Harrison","year":"2018","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"11","key":"10.1016\/j.jisako.2023.07.010_bib39","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1177\/0363546519872219","article-title":"The need for minimum reporting standards for studies of \"biologics\" in sports medicine","volume":"47","author":"Rodeo","year":"2019","journal-title":"Am J Sports Med"},{"issue":"11","key":"10.1016\/j.jisako.2023.07.010_bib40","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1016\/j.arthro.2019.08.016","article-title":"Editorial commentary: platelet-rich plasma: the devil is in the details, and the details need to Be better reported","volume":"35","author":"LaPrade","year":"2019","journal-title":"Arthroscopy"},{"issue":"10","key":"10.1016\/j.jisako.2023.07.010_bib41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2106\/JBJS.16.00793","article-title":"Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells","volume":"99","author":"Murray","year":"2017","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"15","key":"10.1016\/j.jisako.2023.07.010_bib42","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bjsports-2017-098122","article-title":"Infographic: we need minimum reporting standards for biologics","volume":"53","author":"Murray","year":"2019","journal-title":"Br J Sports Med"},{"issue":"5","key":"10.1016\/j.jisako.2023.07.010_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/23259671221093074","article-title":"Assessment of characteristics and methodological quality of the top 50 most cited articles on platelet-rich plasma in musculoskeletal medicine","volume":"10","author":"Bugarin","year":"2022","journal-title":"Orthop J Sports Med"},{"issue":"20","key":"10.1016\/j.jisako.2023.07.010_bib44","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2106\/JBJS.16.01374","article-title":"A\u00a0call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature","volume":"99","author":"Chahla","year":"2017","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"12","key":"10.1016\/j.jisako.2023.07.010_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/23259671211041971","article-title":"Systematic review of platelet-rich plasma for rotator cuff repair: are we adhering to the minimum information for studies evaluating biologics in orthopaedics?","volume":"9","author":"DeClercq","year":"2021","journal-title":"Orthop J Sports Med"},{"issue":"10","key":"10.1016\/j.jisako.2023.07.010_bib46","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00264-022-05566-z","article-title":"Would you have an injection without knowing its formula? New challenges in platelet-rich plasma therapy","volume":"46","author":"Mar\u00edn Ferm\u00edn","year":"2022","journal-title":"Int Orthop"}],"container-title":["Journal of ISAKOS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205977542300545X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205977542300545X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T03:49:25Z","timestamp":1717559365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205977542300545X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S205977542300545X"],"URL":"https:\/\/doi.org\/10.1016\/j.jisako.2023.07.010","relation":{},"ISSN":["2059-7754"],"issn-type":[{"value":"2059-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Dohan Eherenfest et\u00a0al. (2009) on \u201cClassification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of ISAKOS","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jisako.2023.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society of Arthroscopy, Knee Surgery and Orthopedic Sports Medicine.","name":"copyright","label":"Copyright"}]}}